Imipramine treatment of opiate-dependent patients with depressive disorders: A placebo-controlled trial

Archives of General Psychiatry

Volumn 55, Issue 2, 1998, Pages 153-160

  Nunes, Edward V ^a,c   Quitkin, Frederic M ^a,c   Donovan, Stephen J ^a,c   Deliyannides, Deborah ^a   Ocepek Welihson, Katja ^a   Koenig, Teresa ^a   Brady, Ronald ^b   McGrath, Patrick J ^a   Woody, George ^d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Bridge Pl Treatm/Rehab Services ^*  (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; METHADONE;

ABSTINENCE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MOOD; OPIATE ADDICTION; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 0031885280     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.2.153     Document Type: Article

References (66)

1. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5 year follow-up of cocaine use among treated opioid addicts: have our treatments helped? Arch Gen Psychiatry. 1987;44:281-284.
2. Lowinson JH, Marion IJ, Joseph H, Dole VP. Methadone maintenance. In: Lowinson JH, Millman R, Ruiz P, eds. Substance Abuse: A Comprehensive Textbook. 2nd ed. Baltimore, Md: Williams & Wilkins; 1992:550-561.
3. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry. 1989;46:117-121.
4. Arndt IO, Dorozynsky L, Woody GE, McLellan AT, O'Brien CP. Desipramine treatment of cocaine dependence in methadone-maintenance patients. Arch Gen Psychiatry. 1992;49:888-893.
5. Kosten TR, Morgan CM, Falcione J, Schottenfeld RS. Pharmacotherapy for cocaineabusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry. 1992;49:894-898.
6. Weddington WW, Brown BS, Haertzen CA, Hess JM, Mahaffey JR, Kolar AF, Jaffe JH. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse. 1991;17:137-152.
7. Nunes EV, McGrath PJ, Quitkin FM, Ocepek-Welikson K, Stewart JW, Keonig T, Wager S, Klein DF. Imipramine treatment of cocaine abuse: possible boundaries of efficacy. Drug Alcohol Depend. 1995;39:185-195.
8. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D. Imipramine for the treatment of cocaine and methamphetamine dependence. J Addict Dis. 1994;13:201-216.
9. Batki SL, Washburn AM, Delucchi K, Jones RT. A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend. 1996;41:137-142.
10. Covi L, Hess JM, Kreiter NA, Haertzen CA. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse. 1995;21:327-344.
11. Grabowsky J, Rhoades H, Elk R, Schmitz J, Daws C, Creson D, Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled trials. J Clin Psychopharmacol. 1995;15:163-174.
12. Margolin A, Kosten TR, Avants SK, Wilkins J, Ling W, Beckson M. Arndt IO, Cornish J, Ascher JA, Shou-Hua L, Bridge P. A multicenter trial of buproprion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend. 1995;40:125-131.
13. Markou A, Hauger RL, Koob GF. Desmethylimipramine attenuates cocaine with-drawal in rats. Psychopharmacology. 1992;109:305-314.
14. Allen MH, Frances RJ. Varieties of psychopathology found in patients with addictive disorders: a review. In: Meyer RE, ed. Psychopathology and Addictive Disorders. New York, NY: Guilford Press; 1986:17-33.
15. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 1990;264:2511-2518.
16. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment outcome. Arch Gen Psychiatry. 1982;39:151-156.
17. Weissman MD, Slobetz F, Prusoff B, Mesritz M, Howard P. Clinical depression among narcotic addicts maintained on methadone in the community. Am J Psychiatry. 1976;133:1434-1438.
18. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts: a 2.5 year follow-up study. Arch Gen Psychiatry. 1986;43:739-745.
19. LaPorte DJ, McLelian AT, O'Brien CP, Marshaff JR. Treatment response in psychiatrically impaired drug abusers. Compr Psychiatry. 1981;22:411-419.
20. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5 year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry. 1986;43:733-738.
21. Magura S, Siddiqi Q, Freeman RC, Lipton DS. Changes in cocaine use after entry to methacfone treatment. J Addict Dis. 1991;10:31-45.
22. Hatsukami D, Pickens RW. Post treatment depression in an alcohol and drug abuse population. Am J Psychiatry. 1982;139:1563-1566.
23. Carroll KM, Power ME, Bryant K, Rounsaville BJ. One-year follow-up status of treatment-seeking cocaine abusers: psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis. 1993;181:71-79.
24. Childress AR, Enrman RN, McLelton AT, MacRae J, Natale M, D'Brien CP. Can induced moods trigger drug-related responses in opiate patients. J Subst Abuse Treat. 1994;11:17-23.
25. Mariart GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, NY: Guilford Press; 1985.
26. Quitkin FM, Rifkin A, Kaplan J, Klein DF. Phobic anxiety syndrome complicated by drug dependence and addiction: a treatable form of drug abuse. Arch Gen Psychiatry. 1972;27:159-162.
27. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259-1264.
28. Ziedonis DM, Kosten TR. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull. 1991;27:337-343.
29. Goldstein B, McBride D, Westy K, Cited by: Woody GE, O'Brien CP, McLellan AT, Marcovici M, Evans BD. The use of antidepressants with methadone in depressed maintenance patients. Ann NY Acad Sci. 1982;398:124.
30. Kleber HD, Weissman MM, Rounsaville BJ, Wilber CH, Prusoff BA, Riordan CE. Imipramine as treatment for depression in addicts. Arch Gen Psychiatry. 1983;40:649-653.
31. Titievsky J, Seco G, Barranco M, Kyle EM. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study. J Clin Psychiatry. 1982;43:454-456.
32. Woody GE, O'Brien CP, McLelian AT, Marcovici M, Evans BD. The use of antidepressants with methadone in depressed maintenance patients. Ann NY Acad Sci. 1982;398:120-127.
33. Woody GE, O'Brien BP, Rickels K. Depression and anxiety in heroine addicts: a placebo controlled study of doxepin in combination with metfiadone. Am J Psychiatry. 1975;132:447-450.
34. Nunes EV, Quitkin FM, Brady R, Koenig T. Antidepressant treatment in methadone maintenance patients. J Addict Dis. 1994;13:13-24.
35. DeLeon G, Skodol A, Rosenthal MS. Phoenix house: changes in psychopathological signs of resident addicts. Arch Gen Psychiatry. 1973;28:131-135.
36. Willis JH, Osbourne AB. What happens to heroin addicts? a follow up study. Br J Addict. 1978;73:189-198.
37. Rounsaville BJ, Kosten TR, Kleber HD. Long-term changes in current psychiatric diagnoses of treated opiate addicts. Compr Psychiatry. 1986;27:480-498.
38. Meyer RE. How to understand the relationship between psychopathology and addictive disorders: another example of the chicken and the egg. In: Meyer RE, ed. Psychopathology and Addictive Disorders. New York, NY: Guilford Press; 1986.
39. Schuckit MA. Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry. 1986;143:140-147.
40. Nunes E, Quitkin FM, Brady R, Stewart JW. Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use. Am J Psychiatry. 1991;148:667-669.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
42. Spitzer RL, Williams JEW, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry. 1992;49:624-629.
43. Nunes EV, Goehl L, Seracini A, Deliyannides D, Donovan S, Koenig T, Quitkin FM, Williams JBW, Evaluation of depression and panic disorder in methadone patients using a modification of the Structured Clinical Interview for OSM-III-R: test-retest reliability. Am J Addict. 1996;5:241-248.
44. Williams JBW. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45:742-747.
45. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, Md: National Institute of Mental Health: 1976:217-222. US Dept of Health, Education, and Welfare publication ADM 76-338.
46. Sobell MB, Maisto SA, Sobell LC, Cooper AM, Cooper T, Sanders B. Developing a prototype for evaluating alcohol treatment effectiveness. In: Sobell LC, Sobell MO, Ward E, eds. Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. New York, NY: Pergamon Press Inc; 1980:129-150.
47. Gawin FH, Kleber HD. Cocaine abuse treatment: open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry. 1984;41:903-909.
48. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Personal Soc Psychol. 1986;51:1173-1182.
49. Cohen J, Cohen P. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence A Erlbaum Associates: 1983.
50. McGram PJ, Nunes EV, Stewart JW, Goldman DG, Agosti V, Ocepek-Welikson K, Quitkin FM. Imipramine treatment of alcoholics with primary depression: a placebo controlled trial. Arch Gen Psychiatry. 1996;53:232-240.
51. Magura S, Goldsmith D, Casriel C, Goldstein PJ, Lipton D. The validity of methadone clients' self-reported drug use. Int J Addict. 1987;22:727-749.
52. Batki SL, Manfredi LB, Jacob P, Jones RT. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/ benzoylecgonine concentrations. J Clin Psychopharmacol. 1993;13:243-250.
53. Preston KL, Silverman K, Schuster CR, Cone EJ. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction. 1997;92:717-727.
54. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association: 1994.
55. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA. 1996;275:761-767.
56. Nunes EV, Hasin DS. Overview of diagnostic methods: diagnostic criteria, structured and semi-structured interviews, biological markers. In: Kranzler HR, Rounsaville BJ, eds. Dual Diagnosis: Substance Abuse and Comorbid Medical and Psychiatric Disorders. New York, NY: Marcel Dekker Inc; 1998:55-85.
57. Kosten TR, Gawin FH, Morgan C, Nelson JC, Jatlow P. Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse. Am J Drug Alcohol Abuse. 1990;16:329-336.
58. Iguchi MY, Stitzer ML, Bigelow GE, Liebson IA. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend. 1988;22:1-7.
59. Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentive: effects on drug use of methadone maintenance patients. J Consult Clin Psychol. 1992;60:927-934.
60. Carroll KM, Rounsaville BJ, Wich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry. 1994;51:989-997.
61. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry. 1993;150:763-769.
62. Klein DF. Improvements of phase III psychotropic drug trials by intensive phase II work. Neuropsychopharmacology. 1991;4:251-258.
63. Murphy GE, Wetzel RD, Robins E, McEvoy L. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry. 1992;49:459-463.
64. Levy JC, Deykin EY. Suicidality, depression, and substance abuse in adolescence. Am J Psychiatry. 1989;146:1462-1467.
65. Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA. 1992;267:1478-1483.
66. Weissman MM, John K, Merikangas KR, Prusoff BA, Wickramaralne P, Gammon GD, Angold A, Warner V. Depressed parents and their children: general health, social and psychiatric problems. AJDC. 1986;140:801-805.